Science Explorer Back to mapMap

Most cited papers in Male Breast Health Studies

What are the most cited papers in Male Breast Health Studies?

The most cited paper in Male Breast Health Studies is "Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial" (Writing Group for the Women's Health Initiative Investigators, 2002), with 15,961 citations. Next come "Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer" (13,212) and "Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer" (2,868).

Showing 50 of 99 papers. Every paper with more than 379 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial Writing Group for the Women's Health Initiative Investigators · JAMA Open access 17 Jul 2002 15,961
2 Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama et al. · Oncology Open access 2013 13,212
3 Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer José Baselga et al. · New England Journal of Medicine Open access 7 Dec 2011 2,868
4 Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial Bertran Auvert, Dirk Taljaard, Emmanuel Lagarde et al. · PLoS Medicine Open access 18 Oct 2005 2,469
5 Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes Umberto Veronesi, Giovanni Paganelli, Viviana Enrica Galimberti et al. · The Lancet Open access Jun 1997 1,942
6 Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis Armando E. Giuliano, Karla V. Ballman, Linda Mackie McCall et al. · JAMA Open access 12 Sep 2017 1,941
7 Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. Bernard Fisher, Ashley E. Brown, E.P. Mamounas et al. · Journal of Clinical Oncology Jul 1997 1,816
8 Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies The Endogenous Hormones and Breast Cancer Collaborative Group · JNCI Journal of the National Cancer Institute 17 Apr 2002 1,803
9 The Diagnosis and Treatment of Prostate Cancer Mark S. Litwin, Hung‐Jui Tan · JAMA 27 Jun 2017 1,479
10 Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer Bernard Fisher, Stewart Anderson, Carol K. Redmond et al. · New England Journal of Medicine Open access 30 Nov 1995 1,475
11 Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343 Kevin S. Hughes, Lauren A. Schnaper, Jennifer Ruth Bellon et al. · Journal of Clinical Oncology Open access 21 May 2013 1,319
12 Major Causes of Death among Men and Women in China Jiang He, Dongfeng Gu, Xigui Wu et al. · New England Journal of Medicine 14 Sep 2005 1,153
13 Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 Paul Edward Goss, James N. Ingle, Silvana Martino et al. · JNCI Journal of the National Cancer Institute Open access 6 Sep 2005 1,124
14 Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer Bruce George Haffty, Qifeng Yang, Michael Reiß et al. · Journal of Clinical Oncology Open access 21 Nov 2006 1,122
15 Sentinel lymphadenectomy in breast cancer. A. E. Giuliano, Ronald Coy Jones, Murray F. Brennan et al. · Journal of Clinical Oncology Jun 1997 1,106
16 Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal Women Endogenous Hormones Breast Cancer Collaborative Group · JNCI Journal of the National Cancer Institute Open access 19 Aug 2003 1,100
17 Cancer Incidence in BRCA1 Mutation Carriers Douglas Thompson · JNCI Journal of the National Cancer Institute 17 Sep 2002 1,099
18 Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer Kevin S. Hughes, Lauren A. Schnaper, Donald A. Berry et al. · New England Journal of Medicine Open access Sep 2004 1,084
19 Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries Sarah C. Darby, Paul McGale, Carolyn W. Taylor et al. · The Lancet Oncology 6 Jul 2005 1,056
20 Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Bernard Fisher, James J. Dignam, Norman Wolmark et al. · The Lancet Jun 1999 1,045
21 Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation Hanne Meijers-Heijboer, Bert van Geel, Wim L.J. van Putten et al. · New England Journal of Medicine Open access 19 Jul 2001 966
22 Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE Nasim Mavaddat et al. · JNCI Journal of the National Cancer Institute Apr 2013 951
23 Benign Breast Disease and the Risk of Breast Cancer Lynn C. Hartmann, Thomas A. Sellers, Marlene Hanson Frost et al. · New England Journal of Medicine Open access 20 Jul 2005 951
24 MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer Constance Dobbins Lehman, Constantine A. Gatsonis, Christiane Katharina Kuhl et al. · New England Journal of Medicine 28 Mar 2007 945
25 Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy Armando E. Giuliano, Paul S. Dale, Roderick R. Turner et al. · Annals of Surgery Open access Sep 1995 937
26 Lifetime Cancer Risks in Individuals with GermlinePTENMutations Min-Han Tan, Jessica L. Mester, Joanne Yuen Yie Ngeow et al. · Clinical Cancer Research Open access 15 Jan 2012 900
27 National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000 National Institutes of Health Consensus Development Panel · JNCI Journal of the National Cancer Institute 4 Jul 2001 900
28 Annual Report to the Nation on the Status of Cancer, 1975-2000, Featuring the Uses of Surveillance Data for Cancer Prevention and Control Hannah K. Weir · JNCI Journal of the National Cancer Institute 2 Sep 2003 868
29 Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them Paul Linh Nguyen, Shabbir M.H. Alibhai, Shehzad Basaria et al. · European Urology 2 Aug 2014 842
30 Breast carcinoma in men Sharon Hermes Giordano, Deborah S. Cohen, Aman U. Buzdar et al. · Cancer Open access 24 May 2004 794
31 Male breast cancer Ian S. Fentiman, Alain Fourquet, Gabriel N. Hortobágyi · The Lancet Feb 2006 743
32 Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer Donald A. Berry, Constance Cirrincione, I. Craig Henderson et al. · JAMA 11 Apr 2006 732
33 Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review Caitlin C. Murphy, Leona Kay Bartholomew, Melissa Y. Carpentier et al. · Breast Cancer Research and Treatment ReviewOpen access 11 Jun 2012 730
34 Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer Peter C. Albertsen · JAMA 16 Sep 1998 729
35 Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less Bernard Fisher, John Bryant, James J. Dignam et al. · Journal of Clinical Oncology 11 Oct 2002 697
36 Plasma Sex Steroid Hormone Levels and Risk of Breast Cancer in Postmenopausal Women Susan E. Hankinson, Walter Churchill Willett, JoAnn E. Manson et al. · JNCI Journal of the National Cancer Institute Open access 2 Sep 1998 693
37 Sentinel Lymph Node Biopsy in Breast Cancer: Guidelines and Pitfalls of Lymphoscintigraphy and Gamma Probe Detection Paul J. Borgstein, Rik J. Pijpers, Emile F.I. Comans et al. · Journal of the American College of Surgeons Mar 1998 692
38 BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer Fergus J. Couch, Michelle L. DeShano, M. Anne Blackwood et al. · New England Journal of Medicine Open access 15 May 1997 683
39 Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer William U. Shipley et al. · New England Journal of Medicine Open access Feb 2017 676
40 Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer Timothy Joseph Whelan · JNCI Journal of the National Cancer Institute 7 Aug 2002 673
41 Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years Paul Edward Goss, James N. Ingle, Kathleen I. Pritchard et al. · New England Journal of Medicine Open access 5 Jun 2016 656
42 Adult Weight Change and Risk of Postmenopausal Breast Cancer A. Heather Eliassen, Graham A. Colditz, BERNARD A. ROSNER et al. · JAMA 11 Jul 2006 655
43 Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk Marian L. Neuhouser, Aaron K. Aragaki, Ross L. Prentice et al. · JAMA Oncology Open access 11 Jun 2015 647
44 Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective Measurements Sarah A. McLaughlin, Mary Jo Wright, Katherine Teresa Morris et al. · Journal of Clinical Oncology Open access 6 Oct 2008 645
45 Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers Kelly A. Metcalfe, Henry T. Lynch, Parviz Ghadirian et al. · Journal of Clinical Oncology 15 Jun 2004 620
46 Histopathologic Validation of the Sentinel Lymph Node Hypothesis for Breast Carcinoma Roderick R. Turner, David W. Ollila, David L. Krasne et al. · Annals of Surgery Open access Sep 1997 618
47 Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes Beth A Virnig, Todd M. Tuttle, Tatyana Shamliyan et al. · JNCI Journal of the National Cancer Institute Review 13 Jan 2010 615
48 Preservation of Fertility in Patients with Cancer Jacqueline Sara Jeruss, Teresa K. Woodruff · New England Journal of Medicine Open access 25 Feb 2009 585
49 Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. A. J. Nixon, Donna S Neuberg, Daniel F.C. Hayes et al. · Journal of Clinical Oncology May 1994 584
50 Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States) Libby M. Morimoto, Emily D. White, Z. Chen et al. · Cancer Causes & Control Oct 2002 572

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.